Onset of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients
Launched by UNIVERSITY HOSPITAL OSTRAVA · Jan 17, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating when patients with multiple sclerosis (MS) first start to experience problems with their bladder and urinary function, known as lower urinary tract symptoms. Researchers are gathering information by asking patients about their first symptoms and the date they began, and they are also looking at medical records to confirm this information. The goal is to better understand how these symptoms develop in people with MS.
To participate in this study, you need to be an adult who has been diagnosed with multiple sclerosis and willing to provide informed consent, which means you agree to take part after being fully informed about the study. There are no specific exclusions, so if you meet the diagnosis criteria, you may be eligible. If you choose to take part, you can expect to share your experiences during a structured interview, helping researchers gather important data that could improve the understanding and treatment of urinary issues in MS patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of multiple sclerosis
- • adult patients
- • signed informed consent
- Exclusion Criteria:
- • - none
About University Hospital Ostrava
University Hospital Ostrava is a leading medical research institution located in Ostrava, Czech Republic, dedicated to advancing healthcare through innovative clinical trials and research initiatives. As a prominent sponsor of clinical studies, the hospital combines cutting-edge medical technology with a commitment to patient-centered care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a focus on ethical standards and regulatory compliance, University Hospital Ostrava aims to contribute to the development of new therapies and improve treatment outcomes across various medical fields. Its robust research infrastructure and dedication to scientific excellence position it as a key player in the advancement of medical knowledge and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ostrava, Moravian Silesian Region, Czechia
Patients applied
Trial Officials
Jan Krhut, prof.,MD, PhD
Principal Investigator
University Hospital Ostrava
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported